Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TRAX compared with ANAB: revenue, margins and what each company keeps, and the suppliers and customers both name
TRAX
First Tracks Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
ANAB
Anaptysbio, Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
TRAX
First Tracks Biotherapeutics, Inc.
vs
ANAB
Anaptysbio, Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TRAX, solid
ANAB, dashed
Supply-chain overlap
Revenue flow
TRAX: latest quarter not drawable. ANAB: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only TRAX
1
—
Centessa Pharmaceuticals (UK)
unlisted
supplier
Shared
0
No shared counterparties.
Only ANAB
4
VNDA
Vanda Pharmaceuticals
customer
GSK
GSK
customer
—
DRI Healthcare Trust
unlisted
supplier
—
Sagard Healthcare Royalty Partners
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
unlisted
supplier
TRAX
First Tracks Biotherapeutics, Inc.
Change
45.20
▼
−0.06%
· post 45.67
Mkt cap
$1.6B
Revenue
—
Revenue
—
ANAB
Anaptysbio, Inc
Change
48.42
▼
−0.44%
· post 48.43
Closed
Oct 30 '26
Mkt cap
$1.4B
Revenue
$26M
Q1 FY26
Revenue
$235M
FY25
vs
Compare
Closed
Oct 30 '26
TRAX
First Tracks Biotherapeutics, Inc.
vs
ANAB
Anaptysbio, Inc
45.20
▼
−0.06%
post 45.67
Price
48.42
▼
−0.44%
post 48.43
$1.6B
Mkt cap
$1.4B
—
Revenue
$26M
Q1 FY26
—
Revenue
$235M
FY25
Change
Change
TRAX
45.20
▼
−0.06%
vs
ANAB
48.42
▼
−0.44%
Closed
Oct 30 '26